These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10839738)

  • 1. Antibiotic susceptibility of Chlamydia pneumoniae.
    Orfila J
    J Infect Dis; 2000 Jun; 181 Suppl 3():S455. PubMed ID: 10839738
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of antibiotic susceptibility of Chlamydia pneumoniae.
    Hjelm E; Hultén K; Nyström-Rosander C; Gustafsson I; Engstrand L; Cars O
    Scand J Infect Dis Suppl; 1997; 104():13-4. PubMed ID: 9259073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
    J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for antimicrobial resistance in Chlamydia pneumoniae.
    Stamm WE
    J Infect Dis; 2000 Jun; 181 Suppl 3():S456-9. PubMed ID: 10839739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.
    Hammerschlag MR; Roblin PM
    J Antimicrob Chemother; 2004 Jul; 54(1):281-2. PubMed ID: 15190026
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro antibiotic activity against Chlamydia pneumoniae clinical isolates.
    Blasi F; Drago L; Gismondo MR; Cosentini R; Tarsia P; Valenti V; Capone P; Allegra L
    J Chemother; 2003 Feb; 15(1):93-4. PubMed ID: 12678424
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial activity of thiamphenicol-glycinate-acetylcysteinate and other drugs against Chlamydia pneumoniae.
    Lombardi A; Drago L; De Vecchi E; Mombelli B; Gismondo MR
    Arzneimittelforschung; 2001; 51(3):264-7. PubMed ID: 11304944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecillinam has potent in vitro activity against Chlamydophila pneumoniae ATCC VR1310.
    Bostock JM; Geary I; Eley A; Chopra I
    J Antimicrob Chemother; 2004 Jun; 53(6):1112. PubMed ID: 15166212
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation and antimicrobial susceptibilities of Chlamydial isolates from Western barred bandicoots.
    Kumar S; Kutlin A; Roblin P; Kohlhoff S; Bodetti T; Timms P; Hammerschlag MR
    J Clin Microbiol; 2007 Feb; 45(2):392-4. PubMed ID: 17122017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culturing Chlamydophila pneumoniae.
    Walsh F; Willcock J; Amyes SG
    J Chemother; 2002 Jun; 14(3):312-3. PubMed ID: 12120889
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics.
    Cooper MA; Baldwin D; Matthews RS; Andrews JM; Wise R
    J Antimicrob Chemother; 1991 Sep; 28(3):407-13. PubMed ID: 1960121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative multidisciplinary workshop report: detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae.
    Tompkins LS; Schachter J; Boman J; Chernesky MA; Dowell S; Gaydos CA; Levison ME; Maass M; Madico G; Orfila J; Ouchi K; Peeling RW; Taylor-Robinson D; Stamm WE; Wang SP; Blasi F; Relman D
    J Infect Dis; 2000 Jun; 181 Suppl 3():S460-1. PubMed ID: 10839740
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection.
    Beale AS; Masson ND
    J Antimicrob Chemother; 1994 Dec; 34(6):1072-4. PubMed ID: 7730224
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures.
    Alvesalo J; Vuorela H; Tammela P; Leinonen M; Saikku P; Vuorela P
    Biochem Pharmacol; 2006 Mar; 71(6):735-41. PubMed ID: 16414027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cyclooxygenase inhibitors prevent the growth of Chlamydia pneumoniae in HL cells.
    Yan Y; Silvennoinen-Kassinen S; Törmäkangas L; Leinonen M; Saikku P
    Int J Antimicrob Agents; 2008 Jul; 32(1):78-83. PubMed ID: 18524544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae.
    Khan MA; Potter CW; Sharrard RM
    J Antimicrob Chemother; 1996 Apr; 37(4):677-85. PubMed ID: 8722533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1447-8. PubMed ID: 12654690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations.
    Nyström-Rosander C; Hultén K; Gustavsson I; Cars O; Engstrand L; Hjelm E
    Scand J Infect Dis; 1997; 29(5):513-6. PubMed ID: 9435043
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kohlhoff S; Huerta N; Hammerschlag MR
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160287
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneumoniae.
    Yamazaki T; Inoue M; Sasaki N; Hagiwara T; Kishimoto T; Shiga S; Ogawa M; Hara Y; Matsumoto T
    Jpn J Infect Dis; 2003 Aug; 56(4):143-5. PubMed ID: 14583635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.